Chemical Compound

GAMMA-AMANITIN

CAS Registry Number 21150-23-2
GAMMA-AMANITIN chemical structure
Primary Record

GAMMA-AMANITIN

Note: Only for scientific research or as raw materials for production.

In stock
1,921 g
Purity
99.3 %
CAS
21150-23-2

Compound Identifiers & Properties

CAS
21150-23-2
PubChem CID
125121811
SMILES
CC[C@H](C)[C@H]1C(=O)NCC(=O)N[C@H]2C[S@@](=O)C3=C(C[C@@H](C(=O)NCC(=O)N1)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@H](CN4C(=O)[C@@H](NC2=O)CC(=O)N)O)[C@@H](C)[C@H](C)O)C5=C(N3)C=C(C=C5)O
Canonical SMILES
CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@@H]2Cc3c([nH]c4cc(O)ccc34)[S@](=O)C[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H]([C@@H](C)[C@H](C)O)C(=O)N2

Names & Synonyms

  • GAMMA-AMANITIN
  • Amatoxin
  • gamma Amanitin
  • gamma-Amatoxin
  • gammaAmanitine
  • gammaAmatoxin
  • g-Amantin
  • ZOZ8ILM7WM
  • |A-Amanitin
  • .GAMMA.-AMANITIN
  • UNII-ZOZ8ILM7WM
  • AMANITIN, GAMMA-
  • RefChem:639569
  • AMANITIN, .GAMMA.-
  • HSDB 3460
  • DTXSID10897721
  • BADC-00822
  • DTXCID301326941
  • BRN 1070216
  • ZINC263584591
  • 21150-23-2
  • (S)-3-(4-hydroxy-L-isoleucine)-alpha-amanitin
  • alpha-Amanitin, 3-(4-hydroxy-L-isoleucine)-, (S)-
  • .ALPHA.-AMANITIN, 3-((4S)-4-HYDROXY-L-ISOLEUCINE)-
  • ALPHA-AMANITIN, 3-((4S)-4-HYDROXY-L-ISOLEUCINE)-
  • 9,18-(Iminoethaniminoethaniminoethaniminomethano)pyrrolo(1',2':8,9)(1,5,8,11,14)thiatetraazacyclooctadecino(18,17-b)indole-6-acetamide, 1,2,3,5,6,7,8,9,10,12,17,18,19,20,21,22,23,23a-octadecahydro-29-sec-butyl-2,14-dihydroxy-21-(2-hydroxy-1-methylpropyl)-5,8,20,23,24,27,30,33-octaoxo-, 11-oxide
  • CYCLO(L-ASPARAGINYL-4-HYDROXY-L-PROLYL-(S)-4-HYDROXY-L-ISOLEUCYL-6-HYDROXY-2-MERCAPTO-L-TRYPTOPHYLGLYCYL-L-ISOLEUCYLGLYCYL-L-CYSTEINYL) CYCLIC (4->8)-SULFIDE (R)-S-OXIDE
  • (1R,4S,8R,10S,13S,16S,34S)-4-(2-Amino-2-oxoethyl)-34-[(2S)-2-butanyl]-8,22-dihydroxy-13-[(2R,3S)-3-hydroxy-2-butanyl]-2,5,11,14,30,33,36,39-octaoxo-27-thionia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19,21,23-tetraen-27-olate
  • 2-((1R,4S,8R,10S,13S,16S,27R,34S)-34-((2S)-butan-2-yl)-8,22-dihydroxy-13-((2R,3S)-3-hydroxybutan-2-yl)-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo(14.12.11.06,10.018,26.019,24)nonatriaconta-18(26),19(24),20,22-tetraen-4-yl)acetamide
  • 2-[(1R,4S,8R,10S,13S,16S,27R,34S)-34-[(2S)-butan-2-yl]-8,22-dihydroxy-13-[(2R,3S)-3-hydroxybutan-2-yl]-2,5,11,14,27,30,33,36,39-nonaoxo-27|E4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide
  • 2-[(1R,4S,8R,10S,13S,16S,27R,34S)-34-[(2S)-butan-2-yl]-8,22-dihydroxy-13-[(2R,3S)-3-hydroxybutan-2-yl]-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide
  • 58250-15-0